Arlington Trust’s Insmed INSM Stock Holding History

Arlington Trust’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.69K	Buy	+44	New	+$5.33K	﹤0.01%	571

Other funds holding INSM

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MCM

McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Arlington Trust's INSM Position: Q2 2026 in Review

Arlington Trust opened a new position in Insmed (INSM) in Q2 2026: 44 shares worth $4.69K. The stake represents ﹤0.01% of the portfolio and ranks #571 among its holdings.

85 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Arlington Trust held 44 shares of Insmed worth $4.69K as of Q2 2026.
Insmed was a new Arlington Trust position in Q2 2026.
Insmed made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #571 holding.
85 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.